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We investigated the roles of the non-coding transcripts and found that expression of a fragment
containing the 30-untranslated region (30-UTR) of nephronectin in osteoblast progenitor cells
MC3T3-E1 promoted cell differentiation dramatically. We hypothesized that the ectopically
expressed 30-UTR binds microRNAs and modulates their functions. b-Catenin and GSK3b were up-
regulated in the 30-UTR-transfected cells, contributing to the increased cell differentiation, through
reduction of EGFR and ERK phosphorylation. Activator of GSK3b promoted differentiation, while
inhibitor of GSK3b blocked differentiation. Our results indicate that the non-coding transcripts
are important in regulating cell activities and may have potential application for modulating endog-
enous microRNA functions.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
MicroRNAs (miRNAs) are the family of small non-coding nucle-
otides (18–24 bases long) derived from either intron or exon re-
gions of genomic DNA [1,2]. It is believed that miRNAs are
involved in many physiological and pathological phenomena
including control of development [3], cell differentiation [4,5],
apoptosis [6], cell proliferation [7], division [8], immuno-response
[9], protein secretion [10], viral infection [11], and cancer develop-
ment [12]. The biogenesis of miRNA involves several sequential
steps [13]. Initially, the primary microRNAs are transcribed by
RNA polymerase II in the nucleus. They usually form a stem-looped
hairpin structure with imperfect pairing. The primary miRNAs are
then processed into precursor miRNA by a complex of Drosha, an
RNase III enzyme [14]. The precursor miRNAs are delivered fromchemical Societies. Published by E
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3M5. Fax: +1 416 480 5737.nucleus into cytosol by Exportin-5 [15]. Another RNase III enzyme,
Dicer, performs the second cleavage of precursor miRNA to gener-
ate a double-stranded miRNA [16]. One of the single-stranded miR-
NAs is then incorporated into the RNA-induced silencing complex
(RISC), which is mainly composed of Argonaute proteins. It is
known that the miRNA-RISC complex binds to the 30-untranslated
region (30-UTR) of some messenger RNAs and inhibits the target
mRNA translation [17]. The 30-UTRs can also modulate miRNA
functions [18,19].
The complementary binding between the miRNA and the 30-
UTR of its target mRNA contributes to mRNA instability and deg-
radation. However, non-complementary pairing between the miR-
NA and the 30-UTR of the target might affect protein translation.
The detailed mechanism remains illusive. It is not known whether
mRNAs can in turn regulate miRNA functioning. To explore this
possibility, we used nephronectin (Npnt), a widely expressed
integrin a8b1-binding extracellular matrix protein [20–23], as a
model to study the effect of a non-coding fragment of Npnt on
cell activities.
2. Materials and methods
2.1. Plasmid construction
We have previously generated an Npnt expression construct
containing the coding sequence and 600 bp of the 30-UTR in
pcDNA3.1. To study the effect of a non-coding transcript on celllsevier B.V. All rights reserved.
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site on the vector and a site present at nucleotide 1251 of the
coding sequence. Re-ligation of the opened plasmid produced a
plasmid that could no longer express any protein. Rather, a non-
coding transcript was produced driven by the CMV promoter.
The ligated plasmid was transformed into bacteria DH5a and the
single colony harboring this non-coding fragment was then
selected.
A luciferase reporter vector (pMir-Report, Ambion) was used to
generate luciferase reporter construct. Two primers for nephronec-
tin 30-UTR moNpntN30-ScaI (50cccggggagctcccacggagcagccctgtg)
and moNpntC30-MluI (50gggcccacgcgtggcccactctataaccag) were
used to clone the 30-UTR. The PCR product was digested with SacI
and MluI, followed by insertion into a SacI- and MluI-opened pMir-
Report vector. The strategy for generation of the mutant containing
a mutation in the miR-378 target sequence has been described in
detail previously [5].
2.2. Cell differentiation
Differentiation of MC3T3-E1 osteoblast cells was processed by
incubation in differentiation medium (50 lg/ml ascorbic acid,
10 mM 2-glycerophosphate in growth medium) as described
[24,25]. The medium was changed every 2 to 3 days. For inhibitor
studies on cell differentiation, different chemical effectors were
added into the differentiation medium one day after the differenti-
ation induction. The chemicals and their concentrations used were:
dexamethasone (0.1 lM; GSK3b activator), LiCl (40 mM; GSK3b
inhibitor), wortmannin (1 lM; PI3K inhibitor), PD098059 (10 lM;
MEK inhibitor), AG1478 (10 lM; EGFR phosphorylation inhibitor);
k252a (200 nM; TRK inhibitor). The levels of differentiation were
revealed by alkaline phosphatase staining. In general, differenti-
ated cell layers were washed with PBS and then ﬁxed by neutral
formalin (10% formaldehyde in PBS) for 15 min. After removal of
ﬁxation solution and successive incubation in distilled water for
15 min, the cell layers were incubated with staining solution
(1 mg/ml Naphthol AS-MX-PO4; 6 mg/ml fast red violet LB salt,
in 10 mM Tris–HCl, pH 8.0) for 45 min at 37 C. After removal of
staining solution the cells were rinsed three times with water,
and the stained cultures were then kept in distilled water for
microscopic examination.
2.3. RT-PCR
The levels of mRNA in the transfected cells were analyzed by RT-
PCR as described [26,27]. In brief, total RNA was extracted from
1  106 cells using RNeasy mini kit (Qiaqen Inc., ON, Canada).
The cDNAs were synthesized by superscript II reverse transcriptase
(Invitrogen Canada Inc., ON, Canada) using freshly prepared RNA
(2 lg) as template. The samples were incubated as follows: 70 C
to denature DNA for 10 min, 37 C to perform reverse transcription
for 1 h, and 95 C to inactivate reverse transcriptase for 5 min. The
PCR was done using the freshly prepared cDNA as template and
appropriate primers by RedTaq DNA polymerase (Sigma–Aldrich
Canada Ltd., ON, Canada). PCR reactions were carried out with the
following parameters: one cycle at 95 C for 5 min; 30 cycles at
95 C for 30 s, 55 C for 30 s, 72 C for 30 s; andaﬁnal elongation step
at 72 C for 5 min. The primers for 30-UTR of mouse nephronectin
were: 50ctggttatagagtgggcctgctag and 50cccgggtctagaaggaaattccatg
cccaccct. The primers for mouse GAPDH were: 50atggtgaaggtctgtgt-
gatcatc and 50tgggttctcactcctggaagaagg.
For mature microRNA analysis, total RNA was extracted from
1  106 cells using mirVana™ miRNA Isolation Kit (Applied
Biosystems Canada, ON, Canada), followed by cDNA synthesis
using 2 lg RNA. Successive PCR was performed by QuantiMir RT
Kit (System bioscience, CA, USA) using 1 ll cDNA as template.The forward primers used for microRNA detection are listed in
Supplementary Table S1.
2.4. Multiplex PCR identiﬁcation for microRNA-UTR interaction
For in vitro binding of microRNAs with Npnt 30-UTR, a novel
multiplex PCR method was developed. The pcDNA3.1 plasmid con-
taining the 30-UTR of Npnt was used as the template in PCR. Two
different forward primers: p1; 50ctcacagtgtctafagccaaa, and p2;
50cccggggagctcccacggagcagcccctgtg, were used in this multiplex
PCR. The reverse primers for different miRNAs are listed in Supple-
mentary Table S1. In general, the PCR mixture (20 ll) contained:
100 mM KCl, 100 mM (NH4)2SO4, 200 mM Tris HCl, pH 8.75, 1.0%
Triton X-100, 1 mg/ml BSA, 200 lM dNTPs, 2 lM forward primer,
2 lM reverse primer, 1 U Taq DNA polymerase. The parameters
for the PCR reaction were: one cycle at 95 C for 10 min; 35 cycles
at 95 C for 2 min, 37 C for 2 min, 72 C for 2 min; and a ﬁnal elon-
gation step at 72 C for 10 min. The PCR products were then visu-
alized with a 1.5% agarose gel.3. Results and discussion
3.1. Effect of the nephronectin non-coding transcript on osteoblast
differentiation
To study the effect of the Npnt non-coding transcript on osteo-
blast activities, we generated a construct expressing a fragment of
Npnt cDNA containing a portion of the 30-UTR of the mRNA in
pcDNA3.1 named 30-UTR construct (Fig. 1A). Transfection of this
construct into MC3T3-E1 cells elevated the levels of 30-UTR tran-
script as validated by RT-PCR (Fig. 1A). MC3T3-E1 is an osteoblast
progenitor cell line that can be induced to differentiate into osteo-
blasts, a well known marker of which is induction of alkaline phos-
phatase (ALP) activity. Cells stably transfected with the 30-UTR
construct were selected with antibiotics. Pooled cell lines were ob-
tained. The stably transfected cells showed increased cell differen-
tiation substantially upon induction for 2–4 weeks including the
number of differentiated cells (Fig. 1B) and the intensities of ALP
staining (Supplementary Fig. S1A), while cell proliferation re-
mained unchanged (Supplementary Fig. S1B). To corroborate the
results of enhanced cell differentiation by the nephronectin 30-
UTR, we analyzed osteocalcin and Runx2, which are the differenti-
ated osteoblast markers in MC3T3-E1 cells [28,29]. Cells tran-
siently transfected with the 30-UTR produced higher levels of
osteocalcin and Runx2 than the control cell did (Fig. 1C). Change
in cell morphology and formation of nodules were also detected
in the 30-UTR-transfected cells (Fig. 1D).
3.2. Analysis of the interaction between microRNA and the 30-UTR by
PCR
We hypothesized that the ectopically expressed 30-UTR binds
microRNAs and modulates their functions. To test direct interac-
tion of miRNAs with the 30-UTR, we developed a multiplex PCR as-
say to test the potential binding interactions of the miRNAs with
the 30-UTR and to validate the target sites in silico. This method as-
sumes that the miRNAs targeting the 30-UTR could serve as a PCR-
primer, and the PCR products could be generated by a 50-UTR-spe-
ciﬁc primer pairing with the miRNA primer. The nucleotide se-
quence of miRNA-X primer is corresponding to the RNA sequence
of miRNA-X but with a substitution of uridine with thymidine
(Supplementary Table S1). The 30-UTR construct for Npnt is used
as a PCR-template (Fig. 2A). Two different 50-UTR-speciﬁc primers,
of which the targeting sites differ in size by 150 bp on the 30-UTR
construct, are used as the forward primers in two separated PCRs.
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Fig. 1. Expression of a Npnt non-coding fragment promotes cell differentiation. (A) Scheme for the 30-UTR construct of Npnt (upper panel). Over-expression of the 30-UTR
transcript as shown by RT-PCR (lower panel). (B) Over-expression of the 30-UTR transcript promoted MC3T3-E1 cell differentiation as shown by alkaline phosphatase activity.
Differentiated cells were counted per imagine ﬁeld. N = 5, ⁄⁄P < 0.01. (C) MC3T3-E1 cells were transiently transfected with the 30-UTR construct or a control vector and
cultured for 18 days. Total RNA was isolated for real-time PCR analysis to detect expression of Runx2 and Osteocalcin. Transfection with the 30-UTR promoted expression of
Runx2 and Osteocalcin. ⁄ P < 0.05. ⁄⁄ P < 0.01. (D) MC3T3-E1 cells were transiently transfected with the 30-UTR construct or a control vector and cultured for four weeks to
monitor cell morphology and nodule formation, signs of cell differentiation.
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sizes are recognized to be speciﬁc.
We analyzed the potential miRNAs that bind to the 30-UTR of
our construct. A number of candidates with low binding energy
were detected (Supplementary Table S2). We tested 25 different
miRNAs selected from either potential or non-potential candidates
for the 30-UTR of Npnt. As shown in Fig. 2B and Supplementary
Fig. S2, only 6 out of the 25 miRNAs showed positive anticipation
of PCR products. Using this approach, only miR-23a, miR-101a,
miR-296-5p, miR-328, miR-340-3p, and miR-425⁄ were shown to
be positive. For instance, PCR results for miR-296-5p gave a DNA
band of 400 bp using forward primer 1 and 250 bp using forward
primer 2. For further analysis, according to the size of the 30-UTR
construct, the valid DNA dual bands shown in multiplex shouldnot be larger than 920/770 bp. Thus, miR-340-3p should be
excluded from the candidate list because the sizes of the PCR
products are too large. There was no correlation between positive
PCR results and the G/C content or the melting temperature of
primers (Supplementary Table S2), which indicated the speciﬁcity
of miRNAs toward the 30-UTR of Npnt. The pairing structures of the
positive miRNAs with the 30-UTR are listed (Fig. 2C). Initially, we
were thinking that base pair matching of the 30-end of the miRNAs
might be important in generating PCR products, but the results did
not support this. Perhaps, the secondary structures between a miR-
NA and mRNA might be important. This awaits further investiga-
tion. Furthermore, some miRNAs (e.g. miR-378) pairs well with
the target sequence, but no PCR product was obtained. There ap-
pear to be exceptions with this method, and it should be used with
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Fig. 2. Interaction ofmiRNAswith the 30-UTR. (A) Scheme for themultiplex PCRmethod to test the interaction ofmiRNAswithNpnt 30-UTR. Anoligonucleotide corresponding to
miRNA-X is used as a reverse primer. It binds to the potential targeting sites on the antisense strand of the 30-UTR construct, depending on the extent of complementation. Two
forward primers, p1 and p2, dock on different locations of the 30-UTR sequencewere used individually to pair with themiRNA primer for PCR (left). PCR products were obtained
showing the difference in size corresponding to the forward primer (right). (B) SixmiRNAs (miR-23a,miR-101a,miR-296-5p,miR-328,miR-340-3p, andmiR-425⁄) are shown to be
able to generate PCRproductswhile paringwith two forward primers using the 30-UTR construct as a template. The expected sizes of PCR products are indicatedwith arrows. The
miRNA sequences used in this experiment were listed in Supplementary Table S1. (C) Base paring of the miRNAs with potential binding sites of the 30-UTR construct. (D)
Diagram showing the potential target of miR-378 on the 30-UTR of Npnt (AY035898). Mutation was generated in the 30-UTR to abolish the miR-378 binding site (nucleotides in
red). (E) Luciferase activity assays were performed in cells co-transfectedwith the luciferase construct containing the Npnt 30-UTR or themutant andmiR-378. Down regulation
of luciferase activities in the presence of the 30-UTR was abolished when the miR-378 target site was mutated. n = 3, ⁄⁄ P < 0.01.
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method to screen for miRNAs that bind to the 30-UTR of interest.
It is more efﬁcient than the commonly-used luciferase assay and
can be used to conﬁrm the candidate binding sites as identiﬁed
by several tools in silico. This is not to replace any existing meth-
ods. Rather, it adds an alternative approach to identify miRNAs tar-
geting a 30-UTR of interest. It also produces a shorter list of
candidates for validation by luciferase activity assays and transfec-
tion experiments.Since the interaction between miR-378 and the 30-UTR
appeared to have the highest afﬁnity, we generated a luciferase
construct linked with a fragment of the 30-UTR harboring the
miR-378 target site. Mutation was generated in the potential target
site (Fig 2D). In luciferase activity assays, we found that luciferase
activities were repressed in the presence of the 30-UTR when the
construct was co-transfected with miR-378 (Fig. 2E). This inhibi-
tory effect was abolished when the miR-378 target site was
mutated.
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Fig. 3. Promotion of cell differentiation by 30-UTR-transfection is associated with GSK3b-mediated pathway. (A) Cell lysate prepared from cells transfected with the 30-UTR
construct or the control vector were analyzed on Western blot probed with antibodies against a number of proteins as indicated. Up regulation of b-catenin and GSK3b and
down regulation of cyclin D1 were observed. (B) Cell differentiation was performed under the treatment of chemical effectors on GSK3b-related signaling pathway.
Differentiation (ALP-staining) was enhanced when the cells were treated with dexamethasone (Dex, GSK3b activator), and inhibited with LiCl treatment (GSK3b inhibitor).
There was no signiﬁcant effect of wortmannin (WM, PI3K inhibitor). N = 5, ⁄⁄ P < 0.01. (C) Typical intensities of alkaline phosphatase staining are shown. (D) Large
magniﬁcation of differentiated cells after four weeks incubation showing the intensities of ALP activities.
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S.-C. Lee et al. / FEBS Letters 585 (2011) 2610–2616 26153.3. Npnt 30-UTR transcript promoted osteoblast differentiation
through GSK3b-mediated signaling pathway and repression of Erk
phosporylation
Differentiation of mesenchymal stem cells into different cell
types is determined by different transcription factors and signaling
pathways [30]. We suspect that the reason why the 30-UTR en-
hanced cell differentiation might be due to the activation or inhibi-
tion of some differentiation-associated proteins. Expression of b-
catenin increased to two fold and the protein levels of cyclin D1 de-
creased greatly in the 30-UTR-transfected cells (Fig. 3A). Cyclin D1,
which functioned at the early G1 phase through association with
CDK4 or CDK6, was activated by growth factors or mitogenic sig-
nals. A number of transcription factors, extrinsic signals, or intra-
cellular signals regulate cyclin D1 expression positively or
negatively [31]. Although it was not clear which molecules were
responsive for the down-regulation of cyclin D1, the increased b-
catenin and decreased cyclin D1 expression were prone to promote
osteoblast differentiation. We analyzed whether b-catenin is the
potential target of the 30-UTR-binding miRNAs and found thatERK2
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construct or the control vector was analyzed on Western blot probed with antibodies a
observed. (B) Cell differentiation was performed under the treatment of chemical effec
PD098059 (MEK inhibitor) and AG1478 (EGFR kinase inhibitor), but was inhibited by K25
activities are shown.the 30-UTR-binding miRNAs were good candidates for b-catenin-
interaction (Supplementary Fig. S3A–G). It might be that these
miRNAs bind to the 30-UTR freeing b-catenin mRNA for increased
expression of b-catenin protein.
GSK3b is a regulator in the canonical Wnt/b-catenin signaling
pathway [32], which repressed the mesenchymal cell differentia-
tion into adipocytes and chondrocytes, but promoted osteoblast
differentiation [30]. Expression of GSK3b, and phospho GSK3b at
Ser 9 increased in the 30-UTR-transfected cells (Fig. 3A). We ana-
lyzed whether GSK3b is the potential target of the 30-UTR-binding
miRNAs and found that the 30-UTR-binding miRNAs were good
candidates for GSK3b-interaction (Supplementary Fig. S4A–G).
As shown in Fig. 3B–D, the extent of 30-UTR transfected cell dif-
ferentiation increased signiﬁcantly with increasing weeks as re-
ported by alkaline phosphatase (ALP) staining. Not only did the
number of differentiated cell increase (Fig. 3B), but also the size
of nodules (Supplementary Fig. S5), which was the indication of
bone formation in vitro (Supplementary Fig. S6). Under the treat-
ment of dexamethasone (DEX), a glucocoticoid analogue as the
GSK3b activator, osteoblast differentiation increased dramaticallyC vector
Ctrl
Ctrl
PD
AG1487
K252a
3’-UTR
ediated pathway. (A) Cell lysate prepared from cells transfected with the 30-UTR
gainst a number of proteins as indicated. Down regulation of pEGFR and pERK was
tors associated with Erk-signaling pathway. Cell differentiation was promoted by
2a (tyrosine receptor kinase inhibitor). (C) Typical staining of alkaline phosphotase
2616 S.-C. Lee et al. / FEBS Letters 585 (2011) 2610–2616as demonstrated by the size and number of nodules (Fig. 3C) and
intensities of ALP activities (Fig. 3D). In contrast, the number of dif-
ferentiated cells and nodules were signiﬁcantly decreased upon the
treatment with lithium chloride (LiCl), the GSK3b inhibitor. In
addition, there was no effect on incubation with wortmannin,
which implied that the PI3K-related pathway was not affected.
These results strongly suggested that the GSK3b-related pathway
was involved in the 30-UTR-enhanced differentiation.
The mitogen activated protein kinase (MAPK) protein family is
conserved and involved in several cellular processes including cell
proliferation, differentiation, survival, and development. The sig-
naling pathway was activated through either growth factors or
external stimuli, and then conducted the signal through sequential
phosphorylation events [33]. Of all the MAPK subfamilies, extracel-
lular signal related kinase (ERK) is mainly activated by growth fac-
tors. We found that the phosphorylation of EGFR and ERK was
signiﬁcantly inhibited in the 30-UTR-transfected cells (Fig. 4A).
Treatment with PD098059 (MEK1/2 inhibitor) or AG1487 (EGFR
kinase inhibitor) promoted cell differentiation as observed by the
increasing number of differentiated cells (Fig. 4B) and intensity
of ALP staining (Fig. 4C). On the other hand, treatment with
K252a (Trk inhibitor) inhibited cell differentiation. The inhibition
of EGFR and ERK phosphorylation further enhanced the extent of
cell differentiation by the 30-UTR transfection. It implied that the
ERK signaling might be suppressed by the Npnt 30-UTR transcript.
This could be an indirect effect of the 30-UTR.
It is expected that one 30-UTR contains many miRNA binding
sites and one miRNA might target many 30-UTRs. This would create
a balanced network composing of the synergy and counteraction of
miRNA-30-UTR interaction. The homeostasis on miRNAs and miR-
NA-binding sites might be disrupted through changes in the
expression of transcripts or miRNAs. Over-expression of the 30-
UTR of Npnt would affect the expression levels of speciﬁed miRNAs
through competition with the other miRNA-targeting the 30-UTRs.
The formation of miRNA-30-UTR transcript duplex through non-
complementary binding might decrease the functional miRNA lev-
els. Decrease in detection of some mature miRNAs in the 30-UTR-
transfected cells could be due to decreased free miRNAs using
the kit that is designed to isolate small RNAs. There could also be
some mechanisms affecting the expression of these miRNAs in
the 30-UTR-transfected cells. Nevertheless, the interaction of miR-
NAs with the 30-UTR or decrease in miRNA levels would affect pro-
tein expression, leading to enhanced osteoblast differentiation.
One could imagine that the future applications will be beneﬁted
by the application of the 30-UTR transcript in gene therapy. For
example, highly differentiated osteoblast cells, contributed by the
transfection of the 30-UTR transcript of Npnt into progenitor osteo-
blast cells, might be a useful technique for bone transplant and
repair.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2011.07.016.
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